Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Andri Papakonstantinou has been awarded the Pfizer and Swedish Society of Oncology's (SOF) research scholarship in oncology ...

In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin.

Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...